ClinicalTrials.gov research-record snapshot for Cincinnati, OH
Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 9 results; after an exact city/state check of listed facilities, 9 records were retained for Cincinnati, Ohio. It is not a clinic, enrollment, or local-availability directory.
Snapshot methodology and exact-location matching
City/state source filter
Cincinnati, Ohio
Exact-location inclusion rule
A listed facility city and state must match Cincinnati, Ohio.
Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.
Fixed query terms
semaglutide
tirzepatide
cagrilintide
retatrutide
tesamorelin
sermorelin
ipamorelin
bpc-157
thymosin alpha 1
pt-141
Included study statuses
RECRUITING
NOT_YET_RECRUITING
ACTIVE_NOT_RECRUITING
ENROLLING_BY_INVITATION
How to read this snapshot
Research-record limits
This is not a clinic, enrollment, local-service, or local-availability directory.
Why Peptides does not recommend sites, assess eligibility, or provide medical advice.
A listing or study-level status does not prove enrollment, eligibility, safety, effectiveness, or availability.
Each displayed registry status is a study-level overall status, not a facility enrollment status.
Links on this page lead only to the cited ClinicalTrials.gov source records and search pages.
Records are a fixed snapshot, not a complete or live catalog.
All retained records
Study-level status mix
The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.
RECRUITING
1 record
NOT_YET_RECRUITING
2 records
ACTIVE_NOT_RECRUITING
5 records
ENROLLING_BY_INVITATION
1 record
Records in this snapshot
Retained ClinicalTrials.gov NCT records
The retrieved source snapshot contains 9 exact-location records and 8 listed facilities. All 9 retained records are shown below.
Registry title: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
CTI Clinical Research CenterCincinnati, Ohio 45212
Registry title: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
Velocity Clinical Research Inc.Cincinnati, Ohio 45219
Registry title: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
CTI Clinical Research CenterCincinnati, Ohio 45212
Source-query results versus exact-location records
At retrieval, the fixed ClinicalTrials.gov source query returned 9 results. After an exact city/state check of listed facilities, 9 records were retained for Cincinnati, Ohio, across 8 listed facilities. All 9 retained records are shown on this page.
Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.
Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.